Market Research Report
North America Spinal Cord Stimulation Devices Market (2019-2025)
|North America Spinal Cord Stimulation Devices Market (2019-2025)|
Published: September 30, 2019
Content info: 55 Pages
Delivery time: 1-2 business days
The North America Spinal Cord Stimulation Devices Market would witness market growth of 7.54% CAGR during the forecast period (2019-2025). North America dominated the regional market in 2018 and is anticipated to sustain its dominance in the future as well. This trend is associated with increased cases of chronic pain, CRPS, and failed back syndrome. Furthermore, the widespread awareness about spinal cord stimulation therapy, the existence of well-established healthcare settings, and skilled doctors' presence in these settings are expected to boost the market growth. It is also anticipated that the rapid acceptance of technologically advanced products will stimulate market growth.
Although stimulation of the spinal cord is the most established part of the therapeutic family known as neuromodulation, its applications are still evolving. The International Neuromodulation Society defines neuromodulation as a therapeutic contact with the central, peripheral, or autonomic treatment interaction with the nervous system through targeted electrical stimulation or pharmacological delivery from implanted equipment.
Based on Product, the market is segmented into Rechargeable and Non-Rechargeable. Based on Application, the market is segmented into Complex Regional Pain Syndrome, Unsuccessful Disk Surgery, Failed Back Syndrome, Degenerative Disk Disease and Other Applications. Based on countries, the market is segmented into U.S., Mexico, Canada, and Rest of North America.
The market research report covers the analysis of key stake holders of the market. Key companies profiled in the report include Boston Scientific Corporation, Medtronic PLC, Abbott Laboratories (St. Jude Medical, Inc.), Neurosigma, Inc., Nevro Corporation, Synapse BioMedical, Inc., Integer Holdings Corporation, Stimwave Technologies, Inc., Nuvectra Corporation and Saluda Medical Pty Ltd.